Related Macular Degeneration Stocks List

Recent Signals

Date Stock Signal Type
2021-04-15 ADVM MACD Bullish Signal Line Cross Bullish
2021-04-15 ADVM NR7 Range Contraction
2021-04-15 AGTC NR7 Range Contraction
2021-04-15 AGTC Narrow Range Bar Range Contraction
2021-04-15 ALIM MACD Bullish Signal Line Cross Bullish
2021-04-15 APLS Bollinger Band Squeeze Range Contraction
2021-04-15 APLS Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-04-15 APLS 50 DMA Resistance Bearish
2021-04-15 BNTC Fell Below 20 DMA Bearish
2021-04-15 BNTC 200 DMA Support Bullish
2021-04-15 EYPT Bollinger Band Squeeze Range Contraction
2021-04-15 GHSI Lower Bollinger Band Walk Weakness
2021-04-15 GHSI MACD Bearish Signal Line Cross Bearish
2021-04-15 GHSI New Downtrend Bearish
2021-04-15 GRAY New 52 Week Closing Low Bearish
2021-04-15 GRAY Narrow Range Bar Range Contraction
2021-04-15 IRIX Bollinger Band Squeeze Range Contraction
2021-04-15 ISEE Crossed Above 20 DMA Bullish
2021-04-15 ISEE Crossed Above 50 DMA Bullish
2021-04-15 KALA Crossed Above 20 DMA Bullish
2021-04-15 KOD Crossed Above 20 DMA Bullish
2021-04-15 LCTX Bollinger Band Squeeze Range Contraction
2021-04-15 NGM Shooting Star Candlestick Bearish
2021-04-15 NGM Doji - Bearish? Reversal
2021-04-15 OMER 20 DMA Resistance Bearish
2021-04-15 OMER MACD Bullish Signal Line Cross Bullish
2021-04-15 OTLK Lower Bollinger Band Walk Weakness
2021-04-15 REGN Bollinger Band Squeeze Range Contraction
2021-04-15 RGNX Crossed Above 20 DMA Bullish
2021-04-15 RGNX Narrow Range Bar Range Contraction
2021-04-15 RGNX Shooting Star Candlestick Bearish
2021-04-15 RGNX Doji - Bearish? Reversal
2021-04-15 RGNX Lizard Bearish Bearish Day Trade Setup
2021-04-15 RGNX Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-04-15 RGNX NR7 Range Contraction
2021-04-15 TCON MACD Bearish Signal Line Cross Bearish

Recent News for Related Macular Degeneration Stocks

Date Stock Title
Apr 15 REGN More domestic medical supply manufacturing is ‘critical’ for the U.S. : Premier President
Apr 15 REGN Merck hurt by another setback in its battle against COVID-19
Apr 15 REGN Biotech Stock Roundup: GILD's UC Drug Approval, REGN's COVID-19 Antibody Data & More
Apr 15 ADVM Adverum Files Definitive Proxy Materials and Mails Letter to Stockholders Detailing Strength of Team and Acceleration Toward Commercialization of ADVM-022
Apr 14 RGNX REGENXBIO doses first patient in early-stage Hunter Syndrome trial
Apr 14 RGNX REGENXBIO Announces Dosing of First Patient in Cohort 3 of Phase I/II Trial of RGX-121 for the Treatment of MPS II (Hunter Syndrome)
Apr 14 REGN Vaccine transparency is ‘the best course of action’: Doctor 
Apr 14 REGN U.S. in unique position to force increased accountability at the WHO: FDD
Apr 14 KALA JPMorgan: 2 Stocks for Stellar Long-Term Gains
Apr 14 REGN UPDATE 1-Swiss gov't looks to boost domestic COVID-19 vaccine, therapy production
Apr 14 REGN Cramer Gives His Opinion On Regeneron, Bumble And More
Apr 14 REGN Moderna is committed to keep chasing new COVID variants: CEO
Apr 14 ALIM Alimera, Ocumension Ink Licensing Pact For Fluocinolone Acetonide Eye Implant In China
Apr 14 REGN Here's How I'd Treat Regeneron
Apr 14 ALIM Alimera Sciences receives $20M from Ocumension Therapeutics
Apr 14 ALIM Alimera Sciences Receives $20 Million From Ocumension Therapeutics
Apr 14 REGN 'Mad Money' Lightning Round: Regeneron, Bumble, Plug Power
Apr 13 AGTC Applied Genetic and TeamedOn ink licensing deal for gene therapy development
Apr 13 AGTC TeamedOn and AGTC Announce a Licensing Agreement Advancing X-Linked Retinoschisis Gene Therapy Program
Apr 13 APLS Apellis Provides 24-Month Update from Phase 1b Study of Pegcetacoplan in Patients with Geographic Atrophy